The Interdisciplinary Conference on Psychedelic Research (ICPR)

Bexson Biomedical and Stevanato Group Awarded PDA Drug Delivery Innovation Award

Second United States Patent Granted for Small Pharma’s Psychedelics Portfolio

atai Life Sciences Announces Initiation of Phase 1 Proof-of-Concept Clinical Trial...

Silo Pharma extends research pact for Alzheimer’s and Stress Induced Anxiety...

Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform...

PT365 – Dr. Jennifer Montjoy – KAP: Self-Agency Through Intention, Titration,...

Small Pharma Reports Fiscal Second Quarter 2023 Highlights

Revive Therapeutics Announces Finalization of Amended Phase 3 COVID-19 Study Protocol...

Algernon Pharmaceuticals Announces Dr. Rick Strassman author of “DMT: The Spirit...

Load more